CELH
OSCR
A new Wall Street house view
Celsius Holdings just got a fresh opinion from Rothschild & Co, and it’s basically the financial equivalent of “you’re doing fine, but don’t make this awkward.” Analyst Charlie Higgs initiated coverage on the energy drink maker with a Neutral rating and a $47 price target.
Why this matters to your portfolio
Celsius shares were trading around $32.10 on Wednesday, which means the new target still leaves some room to run — but not enough for the analyst to pound the table. In other words, Wall Street is giving Celsius a polite shrug, not a victory lap.
The side quest: Oscar Health
The same story also notes Wolfe Research started coverage on Oscar Health with a Peer Perform rating. That’s useful color for the broader analyst-ratings crowd, but Celsius is the main character here.
Big picture
For investors, initiations like this matter less because of the headline rating and more because they tell you how the Street is framing the stock from here. Neutral usually means: the story isn’t broken, but the easy money might already be in the rearview mirror.